Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients
- 21 May 2020
- journal article
- research article
- Published by Taylor & Francis in Cell Cycle
- Vol. 19 (13), 1632-1640
- https://doi.org/10.1080/15384101.2020.1762038
Abstract
In recent years, studies have revealed HOXA2 as a new oncogene, but its function is unknown in gliomas. We aimed to reveal the relationship between HOXA2 and glioma based on the Chinese Glioma Genome Atlas(CGGA) and the cancer genome atlas (TCGA). HOXA2 expression data and clinically relevant information of glioma patients were obtained from the CGGA and TCGA containing 1447 glioma tissues and five non-tumor brain tissues. The Wilcox or Kruskal tests were used to detect the correlation between the HOXA2 expression level and clinical data of glioma patients. the Kaplan–Meier method were used to examine the relationship between HOXA2 and overall patient survival. Gene set enrichment analysis (GSEA) was conducted to indirectly reveal the signaling pathways involved in HOXA2, and RT-PCR was used to detect HOXA2 expression in gliomas and non-tumor brain tissues. High HOXA2 expression was found to be positively correlated with clinical grade, histological type, age, and tumor recurrence, but negatively correlated with 1p19 codeletion and isocitrate dehydrogenase mutation status.RT-PCR results showed that HOXA2 expression levels were significantly higher in tumor tissues than in non-tumor brain tissues. GSEA showed that HOXA2 promoted the activation of the activation of the JAK-STAT-signaling pathway, focal adhesion, cell-adhesion-molecules-CAMS pathway, cytosolic DNA sensing pathway, and natural killer cell-mediated cytotoxicity. This study revealed for the first time that the novel oncogene,HOXA2, leads to poor prognosis in gliomas, and can be used as a biomarker for the diagnosis and treatment of gliomas.Keywords
Funding Information
- The thousand talents plan of Henan province, Henan Provincial Innovation and Outstanding Talent Program (154200510027)
- Henan provincial science and technology research project: Construction and clinical application of digital precision spine surgery technology system (162102310018)
- Henan Provincial Medical Science and Technology Tackling Program Provincial-Ministerial Co-Construction Project (SBGJ2018076)
This publication has 27 references indexed in Scilit:
- Antitumor activity of methyl gallate by inhibition of focal adhesion formation and Akt phosphorylation in glioma cellsBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewalProceedings of the National Academy of Sciences, 2013
- Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th Annual Frye-Halloran Brain Tumor SymposiumNeurosurgical Focus, 2013
- Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitorsClinical and Experimental Pharmacology and Physiology, 2012
- Molecular markers of glioma: an update on recent progress and perspectivesZeitschrift für Krebsforschung und Klinische Onkologie, 2012
- Molecular targeted therapy in recurrent glioblastoma: current challenges and future directionsExpert Opinion on Investigational Drugs, 2012
- Molecular diagnostics of gliomas: state of the artActa Neuropathologica, 2010
- Activation of JAK/STAT signal pathway predicts poor prognosis of patients with gliomasMedical Oncology, 2010
- YKL-40 Expression is Associated with Poorer Response to Radiation and Shorter Overall Survival in GlioblastomaClinical Cancer Research, 2005
- A Highly Active Homeobox Gene Promoter Regulated by Ets and Sp1 Family Members in Normal Granulosa Cells and Diverse Tumor Cell TypesPublished by Elsevier ,2002